En español
NIDA

NIDA and AstraZeneca partner to develop potential addiction medication

Announcement

May 10, 2013

From concept to medication to treatment graphic

NIDA and AstraZeneca, a global research-based biopharmaceutical company, have joined efforts to explore a novel medication to treat drug addiction. The scientific partnership will explore a specific molecule that modulates the activity of glutamate – an excitatory neurotransmitter. Preclinical studies with this class of molecule indicate that it could be effective for treating a range of mental disorders, including abuse of substances ranging from tobacco to cocaine.

A key strategy of NIDA’s medications development program is to work with pharmaceutical and biotechnology companies to translate basic research findings into medications that treat drug addiction. Further details on NIDA’s efforts in this area can be found at: www.drugabuse.gov/about-nida/organization/divisions/division-pharmacotherapies-medical-consequences-drug-abuse-dpmcda.

For more information, contact the NIDA press office at media@nida.nih.gov or 301-443-6245.


Contact:
NIDA Press Office
301-443-6245
media@nida.nih.gov

About the National Institute on Drug Abuse (NIDA): NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to inform policy and improve practice. Fact sheets on the health effects of drugs of abuse and information on NIDA research and other activities can be found on the NIDA home page at www.drugabuse.gov. To order publications in English or Spanish, call NIDA's new DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or fax or email requests to 240-645-0227 or drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA's media guide can be found at www.drugabuse.gov/publications/media-guide, and its new easy-to-read website can be found at www.easyread.drugabuse.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

This page was last updated May 2013

News Releases

Nov 2014

Oct 2014

Sep 2014

Aug 2014

Jul 2014

Jun 2014

May 2014

Apr 2014

Mar 2014

Feb 2014

Jan 2014

Dec 2013

Nov 2013

Oct 2013

Sep 2013

Aug 2013

Jul 2013

Jun 2013

May 2013

Apr 2013

Mar 2013

Feb 2013

Jan 2013

Dec 2012

Nov 2012

Oct 2012

Sep 2012

Aug 2012

Jul 2012

Jun 2012

May 2012

Apr 2012

Mar 2012

Feb 2012

Jan 2012

Dec 2011

Nov 2011

Oct 2011

Sep 2011

Aug 2011

Jul 2011

Jun 2011

May 2011

Apr 2011

Mar 2011

Jan 2011

Dec 2010

Nov 2010

Sep 2010

Aug 2010

Jul 2010

May 2010

Apr 2010

Mar 2010

Jan 2010

Get this Publication

    Cite this article

    APA style citation

    National Institute on Drug Abuse. NIDA and AstraZeneca partner to develop potential addiction medication Retrieved from http://www.drugabuse.gov/news-events/news-releases/2013/05/nida-astrazeneca-partner-to-develop-potential-addiction-medication

    press ctrl+c to copy